Physician profile
Michael P Schmidt
NPI 1063583086
$3,440.32
in general payments reported to CMS, 2019-2025
17 companies · $34.13 in 2025
The $34.13 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,829 · 2020: $704 · 2021: $660 · 2022: $116 · 2023: $63.12 · 2024: $34.67 · 2025: $34.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $131.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $2,394.02 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $309.24 | 2019-2023 | |
| Amgen INC. | $136.91 | 2020-2024 | Krystexxa |
| Amarin Pharma, INC. | $120.82 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.56 | 2020-2021 | |
| Glaxosmithkline, LLC. | $70.51 | 2019-2025 | Trelegy Ellipta |
| Novo Nordisk INC | $53.36 | 2019 | |
| Biosense Webster, INC. | $50.12 | 2023 | Carto 3 |
| Astrazeneca Pharmaceuticals LP | $47.13 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $31.27 | 2019-2020 | |
| Indivior INC. | $30.99 | 2019-2021 | |
| Abbott Laboratories | $27.60 | 2022 | |
| Lilly USA, LLC | $18.59 | 2024 | Mounjaro |
| Astellas Pharma US INC | $18.04 | 2019 | |
| Abbvie INC. | $17.84 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vivus LLC | $17.57 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.